echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Nature Sub-Journal: Single-cell nuclear sequencing analysis explains the risk of neuroblastoma

    Nature Sub-Journal: Single-cell nuclear sequencing analysis explains the risk of neuroblastoma

    • Last Update: 2021-09-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Neuroblastoma is a childhood cancer that occurs in infants and young children


    Neuroblastoma usually originates in the sympathetic nervous system or adrenal glands


    Co-corresponding author Susanne Schlisio, associate professor of Karolinska Institutet, said: "In our research, we performed single-cell sequencing of healthy adrenal tissues from fetuses, infants, and older children, and compared them with neuroblastoma.


    Researchers collected tumor tissue samples from patients of all ages.


    "We found that low-risk and high-risk neuroblastoma tumors are composed of different cell types, and different cell types also show different malignant potentials," Susanne Schlisio explained


    They found that low-risk neuroblastoma matched the cell type during fetal adrenal development, while aggressive high-risk neuroblastoma matched another cell type, which can only be used in children after birth.


    Analysis of these cell types also revealed different gene expression programs that control the age-related survival conditions at the time of diagnosis


    Oscar Bedoya Reina, the first author and assistant professor at Karolinska Institutet, said: "These special cells help regenerate healthy tissues after birth, but when they become abnormal and cancerous, they can also cause aggressive nerves.


    Now, researchers are preparing to expand their research to understand how the identified progenitor cells undergo further changes after birth, resulting in specialized cell types


    "A detailed understanding of this progenitor cell type will help us make predictions and preliminary verification of future treatment strategies based on tumor differentiation," Susanne Schlisio concluded


    ###


    Bedoya-Reina, OC, Li, W.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.